VISCERAL LEISHMANIASIS IN IMMUNOCOMPROMISED HOSTS

被引：191
|
作者：
FERNANDEZGUERRERO, ML
AGUADO, JM
BUZON, L
BARROS, C
MONTALBAN, C
MARTIN, T
BOUZA, E
机构：
[1] FDN JIMENEZ DIAZ,DIV INTERNAL MED,E-28040 MADRID,SPAIN
[2] UNIV AUTONOMA MADRID,CTR RAMON & CAJAL,CLIN PUERTA HIERRO,MADRID 34,SPAIN
[3] UNIV COMPLUTENSE MADRID,HOSP PROVINCIAL MADRID,MADRID 3,SPAIN
来源：
AMERICAN JOURNAL OF MEDICINE | 1987年 / 83卷 / 06期
关键词：
D O I：
10.1016/0002-9343(87)90948-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1098 / 1102
页数：5
相关论文
共 50 条
  • [1] American visceral leishmaniasis: wild animal hosts
    Lainson, R
    Ishikawa, EAY
    Silveira, FT
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2002, 96 (06) : 630 - 631
  • [2] Validation of serodiagnosis for visceral leishmaniasis in paediatric and immunocompromised patients
    Maia, C.
    Cristovao, J. M.
    Ramada, J.
    Campino, L.
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2007, 12 : 212 - 212
  • [3] GLUCANTIME-RESISTANT VISCERAL LEISHMANIASIS IN IMMUNOCOMPROMISED PATIENTS
    VERDEJO, J
    ALVAR, J
    POLO, RM
    GONZALEZLAHOZ, JM
    [J]. AMERICAN JOURNAL OF MEDICINE, 1988, 85 (01): : 128 - 128
  • [4] Transmission, reservoir hosts and control of zoonotic visceral leishmaniasis
    Quinnell, R. J.
    Courtenay, O.
    [J]. PARASITOLOGY, 2009, 136 (14) : 1915 - 1934
  • [5] Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompromised patients
    Vigna, E.
    De Vivo, A.
    Gentile, M.
    Morelli, R.
    Lucia, E.
    Mazzone, C.
    Recchia, A. G.
    Vianelli, N.
    Morabito, F.
    [J]. TRANSPLANT INFECTIOUS DISEASE, 2010, 12 (05) : 428 - 431
  • [6] AN UNUSUAL CASE OF RELAPSING VISCERAL AND CUTANEOUS LEISHMANIASIS IN AN IMMUNOCOMPROMISED PATIENT
    Jawad, S.
    Dhariwal, A.
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2019, 113 : S163 - S163
  • [7] Treatment of visceral leishmaniasis with liposomal amphotericin B in three immunocompromised patients
    Rodríguez-Wilhelmi, P
    Panizo, C
    Ruza, E
    Rocha, E
    [J]. MEDICINA CLINICA, 2001, 116 (01): : 37 - 38
  • [8] Visceral leishmaniasis:: a threat to immunocompromised patients in non-endemic areas?
    Weisser, M.
    Khanlari, B.
    Terracciano, L.
    Arber, C.
    Gratwohl, A.
    Bassetti, S.
    Hatz, C.
    Battegay, M.
    Flueckiger, U.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2007, 13 (08) : 751 - 753
  • [9] Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases
    Patel, T. A.
    Lockwood, D. N.
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2009, 14 (09) : 1064 - 1070
  • [10] Visceral leishmaniasis in immunocompromised patients with and without AIDS:: a comparison of clinical features and prognosis
    Fernández-Guerrero, ML
    Robles, P
    Rivas, P
    Mójer, F
    Muñíz, G
    de Górgolas, M
    [J]. ACTA TROPICA, 2004, 90 (01) : 11 - 16
12345